6G9H

Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2


Changes made to a PDB entry after its initial release are considered to be either “major” or “minor”. The latest minor version of each major version is available as a file download. More information about the PDB versioning is available.


Version NumberVersion DateVersion Type/Reason Version ChangeRevised CIF Category
1.02018-05-30Initial release
1.12018-06-13Data collection, Database referencescitation
1.22018-06-27Data collection, Database referencescitation
1.32024-11-20Data collection, Database references, Structure summarychem_comp_atom, chem_comp_bond, database_2, pdbx_entry_details, pdbx_modification_feature Download